Cutaneous Leishmaniasis (CL) in Saudi Arabia: Current Status

Authors

  • Haytham Ahmed Zakai Faculty of Applied Medical Sciences, King Abdulaziz University, P.O. Box 80324, Jeddah-21589, Kingdom of Saudi Arabia.

Keywords:

Cutaneous leishmaniasis, Saudi Arabia, Leishmania

Abstract

Cutaneous leishmaniasis (CL) is a major tropical infection of public health importance. It is caused by a group of protozoan intracellular parasites. Several factors contribute to the prevalence and transmission of CL. More than 1400 cases of CL were reported in Saudi Arabia in 2012. Although several studies have looked at CL in Saudi Arabia and emphasized on the Eastern province of the country, the highest prevalence of CL was reported in Al-Qaseem area. In this review, we report on the species of Leishmania parasites causing CL in Saudi Arabia, its distribution and its incidence in the past seven years. We also report on the methods used to diagnose this infection and the treatment protocols used to treat CL in the country.

Downloads

Download data is not yet available.

References

[1]. Reithinger, R., Dujardin, J.C., Louzir, H., Pirmez, C., Alexander, B. and Brooker, S. (2007). Cutaneous leishmaniasis. Lancet Infectious Diseases, 7: 581-596.
[2]. Health Statistical Year Book (2012). Ministry of Health, Saudi Arabia.
[3]. World Health Organization, http://www.who.int/leishmaniasis (accessed on 12 May 2014).
[4]. Health Statistical Year Book (2011). Ministry of Health, Saudi Arabia.
[5]. Health Statistical Year Book (2010). Ministry of Health, Saudi Arabia.
[6]. Health Statistical Year Book (2009). Ministry of Health, Saudi Arabia.
[7]. Health Statistical Year Book (2008). Ministry of Health, Saudi Arabia.
[8]. Health Statistical Year Book (2007). Ministry of Health, Saudi Arabia.
[9]. Health Statistical Year Book (2006). Ministry of Health, Saudi Arabia.
[10]. Zakai, H.A., Chance, M.L. and Bates, P.A. (1998). In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana. Parasitology, 116: 305-309.
[11]. Zakai, H.A., Chance, M.L. and Bates, P.A. (1999). The axenic cultivation of Leishmania donovani amastigotes. Saudi Medical Journal, 20: 334-340.
[12]. http://parasite.org.au/para-site/text/leishmania-text.html (accessed on 12 May 2014).
[13]. El Hassan, A.M. (2014). Cutaneous Leishmaniasis in Al-Ahsa Oasis in Saudi Arabia and in Sudan: A Comparative Study. Saudi Journal of Medicine & Medical Sciences, 1: 64-71.
[14]. Peters, W., Elbihari, S., Liu, C., Le Blancq, S.M., Evans, D.A., Killick-Kendrick, R., Smith, V. and Baldwin, C.I. (1985). Leishmania infecting man and wild animals in Saudi Arabia: 1. General survey. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79: 831-839.
[15]. Al-Zahrani, M.A., Peters, W., Evans, D.A., Smith, V. and Ching Chin, I. (1989). Leishmania infecting man and wild animals in Saudi Arabia. 6. Cutaneous leishmaniasis of man in the south-west. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83: 621-628.
[16]. Elbihari, S., Cheema, A.H. and El-Hassan, A.M. (1987). Leishmania infecting man and wild animals in Saudi Arabia. 4. Canine cutaneous leishmaniasis in the Eastern Province. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81: 925-927.
[17]. Magill, A.J., Grogl, M., Gasser, R.A. Jr, Sun, W. and Oster, C.N. (1993). Visceral infection caused by Leishmania tropica in veterans of operation desert storm. The New England Journal of Medicine, 328 (19): 1383-1387.
[18]. Al-Tawfiq, J.A. and AbuKhamsin, A. (2004). Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956—2002). International Journal of Infectious Diseases, 8: 244-250.
[19]. Al-Qurashi, A.R., Ghandour, A.M., Osman, M. and Al-Juma, M. (2000). Dissemination in cutaneous leishmaniasis due to Leishmania major in different ethnic groups in Saudi Arabia. International Journal of Dermatology, 39: 832-836.
[20]. Amin, T.T., Al-Mohammed, H.I, Kaliyadan, F. and Mohammed, B.S. (2013). Cutaneous leishmaniasis in Al Hassa, Saudi Arabia: epidemiological trends from 2000 to 2010. Asian Pacific Journal of Tropical Medicine, 6: 667-672.
[21]. Postigo, J.A. (2010). Leishmaniasis in the World Health Organization Eastern Mediterranean region. International Journal of Antimicrobial Agents, 36S: S62-S65.
[22]. Al-Zahrani, M.A., Peters, W., Evans, D.A., Chin, C., Smith, V. and Lane, R.P. (1988). Phlebotomus sergenti, a vector of Leishmania tropica in Saudi Arabia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82: 416.
[23]. Goto, H. and Lindoso, J.A. (2010). Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Review of Anti-Infective Therapy, 8: 419–433.
[24]. Vega-Lopez, F. (2003). Diagnosis of cutaneous leishmaniasis. Current Opinion in infectious Diseases, 16: 97–101.
[25]. Al-Hucheimi, S.N., Sultan, B.A. and Al-Dhalimi, M.A. (2009). A comparative study of the diagnosis of Old World cutaneous leishmaniasis in Iraq by polymerase chain reaction and microbiologic and histopathologic methods. International Journal of Dermatology, 48, 404–408.
[26]. Sotto, M.N., Yamashiro-Kanashiro, E.H., da Matta V.L. and de Brito T. (1989). Cutaneous leishmaniasis of the New World: diagnostic immunopathology and antigen pathways in skin and mucosa. Acta Tropica, 46: 121–130.
[27]. Sassi, A., Louzir, H., Ben Salah, A., Mokni, M., Ben Osman, A. and Dellagi, K. (1999). Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clinical Experimental Immunology, 116: 127–132.
[28]. Reed, S.G. (1996). Diagnosis of leishmaniasis. Clinical Dermatology, 14: 471–478.
[29]. Shaw, J.J. and Lainson, R. (1975). Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 69: 323–335.
[30]. Kar, K. (1995). Serodiagnosis of leishmaniasis. Critical Review in Microbiology, 21: 123–152.
[31]. Edrissian, G.H. and Darabian, P. (1979). A comparison of enzyme-linked immunosorbent assay and indirect fluorescent antibody test in the sero-diagnosis of cutaneous and visceral leishmaniasis in Iran. Transactions of the Royal Society of Tropical Medicine and Hygiene, 73: 289–292.
[32]. El-Safi, S.H. and Evans, D.A. (1989). A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83: 334–337.
[33]. Zeyrek, F.Y., Korkmaz, M. and Ozbel, Y. (2007). Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL is highly endemic. Clinical and Vaccine Immunology, 14: 1409–1415.
[34]. Hailu, A. (2002). The use of direct agglutination test (DAT) in serological diagnosis of Ethiopian cutaneous leishmaniasis. Diagnostic Microbiology and Infectious Disease, 42: 251-256.
[35]. Spithill, T.W. and Samaras, N. (1985). The molecular karyotype of Leishmania major and mapping of alpha and beta tubulin gene families to multiple unlinked chromosomal loci. Nucleic Acids Research, 13: 4155-4169.
[36]. Scholler, J.K., Reed, S.G. and Stuart, K. (1986). Molecular karyotype of species and subspecies of Leishmania. Molecular and Biochemical Parasitology, 20: 279-293.
[37]. Samaras, N. and Spithill, T.W. (1987). Molecular karyotype of five species of Leishmania and analysis of gene locations and chromosomal rearrangements. Molecular and Biochemical Parasitology, 25: 279-291.
[38]. Barker, D.C. (1989). Molecular approaches to DNA diagnosis. Parasitology, 99 Suppl: S125-S146.
[39]. Bishop, R.P. and Akinsehinwa, F. (1989). Characterization of Leishmania donovani stocks by genomic DNA heterogeneity and molecular karyotype. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83: 629-634.
[40]. Yehia, L., Adib-Houreih, M., Raslan, W.F., Kibbi, A.G., Loya, A., Firooz, A., Satti, M. El-Sabban, M. and Khalifeh, I. (2012). Molecular diagnosis of cutaneous leishmaniasis and species identification: analysis of 122 biopsies with varied parasite index. Journal of Cutaneous Pathology, 39: 347-355.
[41]. El-Beshbishy, H.A., Al-Ali, K.H. and El-Badry, A.E. (2013). Molecular characterization of cutaneous leishmaniasis in Al-Madinah Al-Munawarah province, western Saudi Arabia. International Journal of Infectious Diseases, 17: e334-338.
[42]. Alkhawajah, A. (1998). Recent trends in the treatment of cutaneous leishmaniasis. Annals of Saudi Medicine, 18: 412-416.
[43]. Zakai, H.A. and Zimmo, S.K. (2000). Effect of itraconazole and terbinafine on Leishmania major promastigotes. Journal of King Abdulaziz University: Medical Sciences, 10: 73-80.
[44]. Zakai, H.A. and Zimmo, S.K. (2000). Effects of itraconazole and terbinafine on Leishmania major lesions on BALB/c mice. Annals of Tropical Medicine & Parasitology, 94: 787-791.
[45]. Alrajhi, A.A., Ibrahim, E.A., De Vol, E.B., Khairat, M., Faris, R.M., Maguire, J.H. (2002). Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. New England Journal of Medicine, 346: 891-895.
[46]. de Macedo-Silva, S.T., Urbina, J.A., de Souza, W. and Rodrigues, J.C.F. (2013). In Vitro Activity of the Antifungal Azoles Itraconazole and Posaconazole against Leishmania amazonensis. PLoS ONE, 8: 1-14.
[47]. Jaffar, H. (2006). Rifampicin in cutaneous leishmaniasis - A therapeutic trial in Saudi Arabia. Journal of Pakistan Association of Dermatologists, 16: 4-9.
[48]. Zakai, H.A., Zimmo, S.K. and Fouad, M.A (2003). Effect of itraconazole and terbinafine on Leishmania promastigotes. Journal of the Egyptian Society of Parasitology, 33: 97-107.
[49]. Al-Jaser, M.H. (2005). Treatment trends of cutaneous leishmaniasis in Saudi Arabia. Saudi Medical Journal, 26: 1220-1224.

Downloads

Published

01-04-2014

How to Cite

Zakai, H. A. (2014). Cutaneous Leishmaniasis (CL) in Saudi Arabia: Current Status. Journal of Advanced Laboratory Research in Biology, 5(2), 21–26. Retrieved from https://e-journal.sospublication.co.in/index.php/jalrb/article/view/181

Issue

Section

Articles